Addictions Therapeutics Market: 48% of Growth to Originate from North America | COVID-19 Impact and Global Analysis by Type and Geography

NEW YORK, June 6, 2022 /PRNewswire/ -- Addictions Therapeutics Market report offers a comprehensive analysis on new product launches, the latest trends, and the post-pandemic impact on businesses. The market value is set to grow by USD 6.30 billion, progressing at a CAGR of almost 6% from 2020 to 2025, as per the latest report by Technavio. Moreover, the market is segmented by type (alcohol addiction therapeutics, tobacco addiction therapeutics, and drug addiction therapeutics), geography (North America, Europe, APAC, and ROW), and key vendors. 

Purchase Our Market Report to uncover new strategies to make the most of future growth opportunities.

Market Segmentation

• By Type- Alcohol addiction therapeutics such as naltrexone, acamprosate, disulfiram, and topiramate are widely used owing to their high efficacy rate. The increasing alcohol addiction cases and the associated health issues are contributing to the growth of the market segment. Moreover, the rising awareness about alcoholism and related health conditions are increasing sales of the mentioned therapeutics, contributing to the addiction therapeutics market size growth. Therefore, the growth of the market segment is expected to be significant during the forecast period.
• By Geography- 48% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for addiction therapeutics in North America. However, market growth in this region will be slower than the growth of the market in APAC. The high consumption of alcohol, tobacco, and opioids leading to addiction is one of the prime factors that will facilitate the addictions therapeutics market growth in North America over the forecast period. 

Download Our Sample Report for more insights on the market share & contribution of various regions & segments

Market Dynamics

• Key Driver

Rising alcohol, opioid, and tobacco addiction are expected to drive the market growth. With the rising alcohol, opioid, and tobacco addiction across the world, many public, private, and government organizations are conducting programs to increase awareness about substance abuse and its health implications. Consequently, the vendors in the addictions therapeutics market are carrying out R&D on novel therapeutics to obtain approvals for their drugs, which will eventually contribute to the growth of their sales volume. As a result of the initiatives to increase awareness about and combat addiction, the next few years will witness the steady growth of the addictions therapeutics market.

• Key Trend

The emergence of free state-run addiction treatment programs and facilities is one of the critical addictions therapeutics market trends. Free state-run addiction treatment programs and facilities are primarily established to help unemployed, homeless, and struggling individuals with substance abuse issues. Moreover, rehabilitation centers are consolidating with treatment drugs, equipment, and service providers to adopt best practices and improve their services. Vendors are also focusing on expanding their functionalities, which is increasing their market exposure.

Buy Our Report Now! for more insights on the drivers, trends, and challenges that will help companies evaluate and develop growth strategies for 2021-2025

Company Profiles

The report analyzes the market's competitive landscape and offers information on several market vendors, including: 

• Alkermes Plc
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Indivior Plc
• Mallinckrodt Plc
• Orexo AB
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Titan Pharmaceuticals Inc.

The addictions therapeutics market is fragmented and the vendors are deploying growth strategies such as M&A to compete in the market.

Download Our Sample Report for more vendors insights with latest product offerings & news

Related Reports

Smoking Cessation and Nicotine De-addiction Market by Product and Geography - Forecast and Analysis 2021-2025: The smoking cessation and nicotine de-addiction market share is expected to increase by USD 18.01 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 11.59%. To get more exclusive research insights: Download Our Sample Report

Celiac Diseases Drugs Market by Therapy Type and Geography - Forecast and Analysis 2021-2025: The celiac disease drugs market has the potential to grow by USD 513.47 million during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 16.92%. To get more exclusive research insights: Download Our Sample Report

Table of Contents

Executive Summary

Market Landscape

• Market ecosystem
• Market characteristics
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020-2025

Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Type

• Market segments
• Comparison by Type
• Alcohol addiction therapeutics - Market size and forecast 2020-2025
• Tobacco addiction therapeutics - Market size and forecast 2020-2025
• Drug addiction therapeutics - Market size and forecast 2020-2025
• Market opportunity by Type

Customer landscape

• Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• APAC - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Competitive scenario
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Alkermes Plc
• Emergent BioSolutions Inc.
• GlaxoSmithKline Plc
• Indivior Plc
• Mallinckrodt Plc
• Orexo AB
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Titan Pharmaceuticals Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/addictions-therapeutics-market-48-of-growth-to-originate-from-north-america--covid-19-impact-and-global-analysis-by-type-and-geography-301561002.html

SOURCE Technavio